Compass Financial Management LLC Acquires New Holdings in McKesson Corporation $MCK

Key Points

• Compass Financial Management acquired 2,822 McKesson shares worth approximately $2.34 million in the second quarter, while institutional investors collectively own 85.07% of the company.
• McKesson exceeded quarterly expectations with adjusted earnings of $9.93 per share and revenue of $105.38 billion, up 7.7% year over year. The company issued fiscal 2027 EPS guidance of $44.20–$45.00.
• McKesson raised its quarterly dividend to $0.94 per share, or $3.76 annually, while analysts maintain a “Moderate Buy” consensus and an average price target of $973.44.

Compass Financial Management LLC bought a new stake in shares of McKesson Corporation (NYSE:MCK - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,822 shares of the company's stock, valued at approximately $2,341,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of MCK. BlackRock Inc. acquired a new position in shares of McKesson during the second quarter worth approximately $8,156,743,000. Norges Bank acquired a new stake in McKesson in the 4th quarter valued at approximately $1,651,137,000. Bank of America Corp DE acquired a new stake in McKesson in the 2nd quarter valued at approximately $998,896,000. Legal & General Group Plc bought a new stake in McKesson during the 2nd quarter valued at $656,566,000. Finally, The Manufacturers Life Insurance Company bought a new stake in McKesson during the 2nd quarter valued at $651,462,000. Institutional investors own 85.07% of the company's stock.

McKesson Stock Performance

Shares of NYSE MCK opened at $907.35 on Friday. The stock has a fifty day moving average price of $848.13 and a two-hundred day moving average price of $843.09. The firm has a market cap of $105.79 billion, a P/E ratio of 24.28, a PEG ratio of 1.81 and a beta of 0.30. McKesson Corporation has a 1 year low of $682.35 and a 1 year high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping analysts' consensus estimates of $9.56 by $0.37. The company had revenue of $105.38 billion for the quarter, compared to the consensus estimate of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The company's quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, research analysts predict that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a $0.94 dividend. This represents a $3.76 annualized dividend and a yield of 0.4%. This is a boost from McKesson's previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson's dividend payout ratio (DPR) is presently 10.06%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 8,463 shares of McKesson stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total value of $6,715,898.28. Following the transaction, the chief executive officer owned 5,919 shares of the company's stock, valued at $4,697,081.64. The trade was a 58.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the business's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 22,156 shares of company stock valued at $17,305,242 over the last three months. 0.06% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Evercore reissued an "outperform" rating on shares of McKesson in a research note on Thursday, August 6th. Robert W. Baird set a $1,015.00 price objective on shares of McKesson in a research note on Thursday, August 6th. Wells Fargo & Company upped their price objective on shares of McKesson from $812.00 to $933.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 11th. Royal Bank Of Canada began coverage on shares of McKesson in a research report on Wednesday, August 19th. They issued a "sector perform" rating and a $845.00 target price for the company. Finally, TD Cowen raised their target price on shares of McKesson from $989.00 to $1,006.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $973.44.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source